BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/14/2014 1:43:00 PM | Browse: 565 | Download: 962
Publication Name World Journal of Ophthalmology
Manuscript ID 12013
Country Türkiye
Received
2014-06-17 15:10
Peer-Review Started
2014-06-18 17:22
To Make the First Decision
2014-07-29 11:52
Return for Revision
2014-08-07 08:40
Revised
2014-08-26 21:28
Second Decision
2014-09-17 13:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-09-17 14:26
Articles in Press
2014-09-17 14:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-11-04 16:40
Publish the Manuscript Online
2014-11-14 13:11
ISSN 2218-6239 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Ophthalmology
Manuscript Type Minireviews
Article Title Current evidence of pathophysiology of diabetic macular edema: A review
Manuscript Source Invited Manuscript
All Author List Gunhal Satirtav, Refik Oltulu and Hurkan Kerimoglu
Funding Agency and Grant Number
Corresponding Author Gunhal Satirtav, MD, Ophthalmology Department, Necmettin Erbakan University Meram School of Medicine, Meram Tıp Fakultesi Hastanesi, Goz hastalıkları AD S-Blok 3. Kat, Meram, Konya 42800, Turkey. gunhal@gmail.com
Key Words Diabetes mellitus; Macular edema; Pathophysiology; Vascular endothelial growth factor; Inflammation
Core Tip Diabetic macular edema (DME) is an important cause of vision loss in patients with diabetes mellitus. The pathophysiology of DME can be described as a process whereby hyperglycaemia leads to overlapping and inter-related pathways that play a role not only in the initial vascular events, but also in the events that cause the edema to become chronic. On a macrocellular level, DME is believed to be in part caused by alterations in hydrostatic and oncotic pressures and shear stress. Angiogenic factor expression, inflammation and oxidative stress constitute the key components of microvascular pathways. The interactions, signalling events and feedback loops between the various molecules are complicated and are not completely understood. These molecular mediators, acting in conjunction with macrocellular factors, which are all stimulated in part by the hyperglycaemia and hypoxia, can have a direct endothelial effect leading to hyperpermeability, disruption of vascular endothelial cell junctions, and leukostasis. Macular edema is thought to be caused as a result of these consequences.
Publish Date 2014-11-14 13:11
Citation Satirtav G, Oltulu R, Kerimoglu H. Current evidence of pathophysiology of diabetic macular edema: A review. World J Ophthalmol 2014; 4(4): 147-151
URL http://www.wjgnet.com/2218-6239/full/v4/i4/147.htm
DOI http://dx.doi.org/10.5318/wjo.v4.i4.147
Full Article (PDF) WJO-4-147.pdf
Full Article (Word) WJO-4-147.doc
Manuscript File 12013-Review.doc
Answering Reviewers 12013-Answering reviewers.pdf
Copyright License Agreement 12013-Copyright assignment.pdf
Peer-review Report 12013-Peer review(s).pdf
Scientific Misconduct Check 12013-CrossCheck.jpg
Scientific Editor Work List 12013-Scientific editor work list.pdf